When the Inflation Reduction Act passed the Senate Sunday, Republicans successfully blocked a price cap on insulin. Robert Weissman, president of Public Citizen, says that despite its flaws, the bill is a win against the pharmaceutical industry’s exploitative profits. “They’re super worried that this is a break in the dam and that it will lead to more negotiation, once we, the American people, see plainly the cost savings that are available,” says Weissman.
This content originally appeared on Democracy Now! and was authored by Democracy Now!.
Democracy Now! | Radio Free (2022-08-09T12:16:08+00:00) Under Senate Bill, Medicare Can Negotiate Some Drug Prices, But Power to Lower Prices Remains Limited. Retrieved from https://www.radiofree.org/2022/08/09/under-senate-bill-medicare-can-negotiate-some-drug-prices-but-power-to-lower-prices-remains-limited/
Please log in to upload a file.
There are no updates yet.
Click the Upload button above to add an update.